小药师
Lv51
840 积分
2023-10-31 加入
-
Adverse events related to radium-223 treatment: "real-life" data from the Eudra-Vigilance database
7小时前
已完结
-
The Association Between Use of Rivastigmine and Pneumonia: Systematic Analysis of FDA Adverse Event Reporting System
3天前
已完结
-
An exploratory study evaluating the 30 medications most commonly associated with headaches in the FDA Adverse Event Reporting System
4天前
已完结
-
Comprehensive safety profile of dipeptidyl peptidase-4 inhibitors: a post-marketing study based on FAERS database using signal detection algorithms
7天前
已完结
-
A real-world disproportionality analysis of anti-VEGF drugs from the FDA Adverse Event Reporting System
8天前
已完结
-
Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial
10天前
已完结
-
A Brief Review of Gepants
10天前
已完结
-
Preventive Treatment of Migraine
10天前
已完结
-
Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial
10天前
已完结
-
Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial
10天前
已完结